BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11547945)

  • 1. Characterization of refractile eosinophilic granular cells in oligodendroglial tumors.
    Yoshida T; Nakazato Y
    Acta Neuropathol; 2001 Jul; 102(1):11-9. PubMed ID: 11547945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.
    Herpers MJ; Budka H
    Acta Neuropathol; 1984; 64(4):265-72. PubMed ID: 6391068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granular cells in oligodendroglioma suggest a neoplastic change rather than a reactive phenomenon: case report with molecular characterisation.
    Rao S; Sravya P; Chandran C; Saini J; Somanna S; Santosh V
    Brain Tumor Pathol; 2017 Jan; 34(1):42-47. PubMed ID: 27738816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural characterization of transitional cells in oligodendrogliomas.
    Kros JM; de Jong AA; van der Kwast TH
    J Neuropathol Exp Neurol; 1992 Mar; 51(2):186-93. PubMed ID: 1538242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic characteristics of GFAP-immunopositive oligodendroglial tumours Part I: immunohistochemical study.
    Matyja E; Taraszewska A; Zabek M
    Folia Neuropathol; 2001; 39(1):19-26. PubMed ID: 11678347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
    Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytologic characteristics of intracytoplasmic refractile eosinophilic granular bodies in anaplastic oligodendroglioma: a case report.
    Kojima H; Mori K; Fukudome N; Iseki M; Shimizu S
    Acta Cytol; 2008; 52(4):467-70. PubMed ID: 18702367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characteristics of GFAP-positive oligodendroglial tumours. Part II: ultrastructural study.
    Matyja E; Taraszewska A; NagaƄska E; Zabek M
    Folia Neuropathol; 2001; 39(2):103-10. PubMed ID: 11680631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas.
    Kros JM; Van Eden CG; Stefanko SZ; Waayer-Van Batenburg M; van der Kwast TH
    Cancer; 1990 Sep; 66(6):1204-12. PubMed ID: 2205356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendroglioma with signet-ring cell morphology: a case report with an immunohistochemical and ultrastructural study.
    Mikami Y; Shirabe T; Hata S; Watanabe A
    Pathol Int; 1998 Feb; 48(2):144-50. PubMed ID: 9589479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive immunohistochemical profiles of small heat shock proteins (heat shock protein 27 and alpha B-crystallin) in human brain tumors.
    Hitotsumatsu T; Iwaki T; Fukui M; Tateishi J
    Cancer; 1996 Jan; 77(2):352-61. PubMed ID: 8625245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytic characteristics of oligodendroglioma. Fine structural and immunohistochemical studies of two cases.
    Kamitani H; Masuzawa H; Sato J; Kanazawa I
    J Neurol Sci; 1987 May; 78(3):349-55. PubMed ID: 3585407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of malignant features in oligodendroglial tumors.
    Saito A; Nakazato Y
    Clin Neuropathol; 1999; 18(2):61-73. PubMed ID: 10192700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical and ultrastructural studies of eosinophilic granular bodies in astrocytic tumors.
    Murayama S; Bouldin TW; Suzuki K
    Acta Neuropathol; 1992; 83(4):408-14. PubMed ID: 1575017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendrogliomas with abundant refractile eosinophilic granular cells.
    Au K; Bilbao J; Mainprize T; Schwartz M; Keith J
    Can J Neurol Sci; 2013 Sep; 40(5):746-8. PubMed ID: 23968956
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelin basic protein as a possible marker for oligodendroglioma.
    Tanaka J; Hokama Y; Nakamura H
    Acta Pathol Jpn; 1988 Oct; 38(10):1297-303. PubMed ID: 2464269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MBP and GFAP immunohistochemistry of oligodendrogliomas with relationship to myelin-forming glia in cell differentiation].
    Hokama Y; Tanaka J; Nakamura H; Hori T
    No To Shinkei; 1986 Apr; 38(4):379-86. PubMed ID: 2424482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nogo-A expression in oligodendroglial tumors.
    Jung TY; Jung S; Lee KH; Cao VT; Jin SG; Moon KS; Kim IY; Kang SS; Kim HS; Lee MC
    Neuropathology; 2011 Feb; 31(1):11-9. PubMed ID: 20487307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling study.
    Kros JM; Schouten WC; Janssen PJ; van der Kwast TH
    Acta Neuropathol; 1996; 91(1):99-103. PubMed ID: 8773153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosenthal fibers producing a granular cell appearance in a glioblastoma.
    Del Bigio MR; Deck JH
    Acta Neuropathol; 1993; 86(1):100-4. PubMed ID: 8396834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.